Source: Parexel News Release BOSTON and Durham, N.C. May 20, 2021 — Parexel, a leading global clinical research organization (CRO), today announced the release of “Discussions on Diversity,” an in-depth research report and interactive microsite featuring patient, academic and physician voices highlighting the importance of diversity in clinical trials. The report, issued in …
Read More »
In 2015, the U.S. Food and Drug Administration launched a five-year action plan, aiming to improve diversity in clinical trials for newly approved drugs. According to HealthDay, Angela K. Green, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues analyzed Snapshots data to examine whether …
Read More »
COVID-19 vaccine trials have moved into phase three. Two trials were launched in the United States and researchers are looking to enroll 30,000 people for each trial. They are working to ensure that a significant percentage of volunteers come from the places hit hardest. Dr. Sam Oh, Director of Epidemiology for …
Read More »
Diversity MD
